Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 9, 2016, Pages E1286-E1295

  Ryan, John F ^a   Hovde, Rachel ^a   Glanville, Jacob ^a   Lyu, Shu Chen ^a   Ji, Xuhuai ^a   Gupta, Sheena ^a   Tibshirani, Robert J ^b   Jay, David C ^a   Boyd, Scott D ^a   Chinthrajah, R Sharon ^a   Davis, Mark M ^a   Galli, Stephen J ^a   Maecker, Holden T ^a   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Anergy; Gene expression; Immunotherapy; T cells; Tolerance

Indexed keywords

ALLERGEN; ALPHA4 INTEGRIN; BETA7 INTEGRIN; CD27 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 6; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SELECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; MALE; ORAL IMMUNOTHERAPY; PATIENT MONITORING; PEANUT ALLERGY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; IMMUNOLOGY; IMMUNOTHERAPY;

ALLERGENS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY; T-LYMPHOCYTE SUBSETS;

EID: 84959545704     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1520180113     Document Type: Article

References (55)

1. Larché M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6(10):761-771.
2. Wambre E, et al. (2012) Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol 129(2):544-551, 551.e1-551.e7.
3. Akdis M, Akdis CA (2009) Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov 8(8):645-660.
4. Bedoret D, et al. (2012) Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol 5(3):267-276.
5. Burks AW, et al. (2011) NIAID-sponsored 2010 guidelines for managing food allergy: Applications in the pediatric population. Pediatrics 128(5):955-965.
6. Turcanu V, Maleki SJ, Lack G (2003) Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J Clin Invest 111(7):1065-1072.
7. Syed A, et al. (2014) Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 133(2):500-510.
8. Herold KC, Bluestone JA (2011) Type 1 diabetes immunotherapy: Is the glass half empty or half full? Sci Transl Med 3(95):95fs1.
9. Francis JN, Till SJ, Durham SR (2003) Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111(6):1255-1261.
10. Vickery BP, et al. (2014) Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 133(2):468-475.
11. Tang ML, et al. (2015) Administration of a probiotic with peanut oral immunotherapy: A randomized trial. J Allergy Clin Immunol 135(3):737-44.e8.
12. Sewell WAC, Dore PC (2004) Premature testing of allergen-specific IgE post-anaphylaxis may cause false negative results. J Allergy Clin Immunol 113(2):S241.
13. Jones SM, et al. (2009) Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124(2):292-300, 300.e1-300.e97.
14. Brinkmann V, Heusser CH (1993) T cell-dependent differentiation of human B cells into IgM, IgG, IgA, or IgE plasma cells: High rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE precursors. Cell Immunol 152(2):323-332.
15. Stapel SO, et al.; EAACI Task Force (2008) Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy 63(7):793-796.
16. Vasquez-Ortiz M, et al. (2014) Ovalbumin-specific IgE/IgG4 ratio might improve the prediction of cooked and uncooked egg tolerance development in egg-allergic children. Clin Exp Allergy 44:579-588.
17. van Neerven RJ, et al. (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163(5):2944-2952.
18. Wambre E, James EA, Kwok WW (2012) Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol 24(6):700-706.
19. Standifer NE, Burwell EA, Gersuk VH, Greenbaum CJ, Nepom GT (2009) Changes in autoreactive T cell avidity during type 1 diabetes development. Clin Immunol 132(3): 312-320.
20. Burton BR, et al. (2014) Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun 5:4741.
21. Han A, Glanville J, Hansmann L, Davis MM (2014) Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol 32(7):684-692.
22. Hong JW, Quake SR (2003) Integrated nanoliter systems. Nat Biotechnol 21(10): 1179-1183.
23. Burks AW, et al. (1992) Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 90(6 Pt 1):962-969.
24. Maecker HT, et al. (2012) New tools for classification and monitoring of autoimmune diseases. Nat Rev Rheumatol 8(6):317-328.
25. Tibshirani R, Walther G, Hastie T (2001) Estimating the number of clusters in a data set via the gap statistic. J R Stat Soc Series B Stat Methodol 63(2):411-423.
26. DeLong JH, et al. (2011) Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 127(5):1211-8.e3.
27. Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC (2014) Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 58(2-3):358-368.
28. Lechner O, et al. (2001) Fingerprints of anergic T cells. Curr Biol 11(8):587-595.
29. Aslam A, Chan H, Warrell DA, Misbah S, Ogg GS (2010) Tracking antigen-specific T-cells during clinical tolerance induction in humans. PLoS One 5(6):e11028.
30. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21:713-758.
31. Steinke JW, Lawrence MG (2014) T-cell biology in immunotherapy. Ann Allergy Asthma Immunol 112(3):195-199.
32. Tran DQ (2012) TGF-β: The sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 4(1):29-37.
33. Gorelik L, Fields PE, Flavell RA (2000) Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165(9):4773-4777.
34. Komine O, et al. (2003) The Runx1 transcription factor inhibits the differentiation of naive CD4+ T cells into the Th2 lineage by repressing GATA3 expression. J Exp Med 198(1):51-61.
35. Shalek AK, et al. (2014) Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature 510(7505):363-369.
36. Schleifman EB, et al. (2014) Targeted biomarker profiling of matched primary and metastatic estrogen receptor positive breast cancers. PLoS One 9(2):e88401.
37. Pollen AA, et al. (2014) Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat Biotechnol 32(10):1053-1058.
38. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV (2000) In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 6(3):337-342.
39. Akdis M, Akdis CA (2014) Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133(3):621-631.
40. Fathman CG, Lineberry NB (2007) Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol 7(8):599-609.
41. Rudd CE, Taylor A, Schneider H (2009) CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 229(1):12-26.
42. Nishikawa H, Sakaguchi S (2014) Regulatory T cells in cancer immunotherapy. Curr Opin Immunol 27:1-7.
43. Walker LS (2013) Treg and CTLA-4: Two intertwining pathways to immune tolerance. J Autoimmun 45:49-57.
44. Dalai SK, Mirshahidi S, Morrot A, Zavala F, Sadegh-Nasseri S (2008) Anergy in memory CD4+ T cells is induced by B cells. J Immunol 181(5):3221-3231.
45. David A, et al. (2014) Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation. Proc Natl Acad Sci USA 111(21):7735-7740.
46. Scadding GW, et al. (2010) Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 40(4):598-606.
47. Hjorth M, et al. (2011) GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients. Clin Immunol 138(1):117-126.
48. Suárez-Fueyo A, et al. (2014) Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol 133(1):130-8.e1, 2.
49. Loo EW, Krantz MJ, Agrawal B (2012) High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients. Cell Immunol 280(1):10-15.
50. Savilahti EM, Savilahti E (2013) Development of natural tolerance and induced desensitization in cow's milk allergy. Pediatr Allergy Immunol 24(2):114-121.
51. Santos AF, et al. (2014) Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol 134(3):645-652.
52. Gernez Y, et al. (2011) Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol 154(4):318-327.
53. Do JH, Choi DK (2008) Clustering approaches to identifying gene expression patterns from DNA microarray data. Mol Cells 25(2):279-288.
54. Ringnér M (2008) What is principal component analysis? Nat Biotechnol 26(3):303-304.
55. Coutsias EA, Seok C, Dill KA (2004) Using quaternions to calculate RMSD. J Comput Chem 25(15):1849-1857.